Sex hormonal regulation of cardiac ion channels in drug-induced QT syndromes

Pharmacology and Therapeutics

Volumn 168, Issue , 2016, Pages 23-28

  Kurokawa, Junko ^a   Kodama, Masami ^a   Clancy, Colleen E ^b   Furukawa, Tetsushi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arrhythmias; Cardiac repolarization; Gender difference; Sex hormones

Indexed keywords

ESTROGEN; ION CHANNEL; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

DRUG INDUCED DISEASE; HEART REPOLARIZATION; HORMONAL REGULATION; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; ANIMAL; CHEMICALLY INDUCED; FEMALE; GENOMICS; MALE; MENSTRUAL CYCLE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; TORSADES DE POINTES;

ANIMALS; FEMALE; GENOMICS; GONADAL STEROID HORMONES; HUMANS; ION CHANNELS; LONG QT SYNDROME; MALE; MENSTRUAL CYCLE; PROGESTERONE; RISK FACTORS; SEX FACTORS; TESTOSTERONE; TORSADES DE POINTES;

EID: 84995426536     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2016.09.004     Document Type: Review

References (67)

1. Abi-Gerges, N., Philp, K., Pollard, C., Wakefield, I., Hammond, T.G., Valentin, J.P., Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes. Fundam Clin Pharmacol 18:2 (2004), 139–151.
2. Abriel, H., Schlapfer, J., Keller, D.I., Gavillet, B., Buclin, T., Biollaz, J., et al. Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy. Swiss Med Wkly 134:47–48 (2004), 685–694.
3. Anneken, L., Baumann, S., Vigneault, P., Biliczki, P., Friedrich, C., Xiao, L., et al. Estradiol regulates human QT-interval: acceleration of cardiac repolarization by enhanced KCNH2 membrane trafficking. Eur Heart J 37:7 (2016), 640–650.
4. Asada, K., Kurokawa, J., Furukawa, T., Redox- and calmodulin-dependent S-nitrosylation of the KCNQ1 channel. J Biol Chem 284:9 (2009), 6014–6020.
5. Bai, C.X., Kurokawa, J., Tamagawa, M., Nakaya, H., Furukawa, T., Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 112:12 (2005), 1701–1710.
6. Baron, S., Manin, M., Beaudoin, C., Leotoing, L., Communal, Y., Veyssiere, G., et al. Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J Biol Chem 279:15 (2004), 14579–14586.
7. Bazett, H.C., An analysis of the time-relations of electrocardiograms. Heart 7 (1920), 353–370.
8. Bidoggia, H., Maciel, J.P., Capalozza, N., Mosca, S., Blaksley, E.J., Valverde, E., et al. Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. Am Heart J 140:4 (2000), 678–683.
9. Brouillette, J., Rivard, K., Lizotte, E., Fiset, C., Sex and strain differences in adult mouse cardiac repolarization: importance of androgens. Cardiovasc Res 65:1 (2005), 148–157.
10. + channel structure–activity relationships and mechanisms of drug-induced QT prolongation. Annu Rev Pharmacol Toxicol 43 (2003), 441–461.
11. Di Diego, J.M., Cordeiro, J.M., Goodrow, R.J., Fish, J.M., Zygmunt, A.C., Perez, G.J., et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 106:15 (2002), 2004–2011.
12. Drici, M.D., Burklow, T.R., Haridasse, V., Glazer, R.I., Woosley, R.L., Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 94:6 (1996), 1471–1474.
13. Drici, M.D., Knollmann, B.C., Wang, W.X., Woosley, R.L., Cardiac actions of erythromycin: influence of female sex. JAMA 280:20 (1998), 1774–1776.
14. Faber, G.M., Rudy, Y., Action potential and contractility changes in [Na(+)](i) overloaded cardiac myocytes: a simulation study. Biophys J 78:5 (2000), 2392–2404.
15. Fermini, B., Fossa, A.A., The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2:6 (2003), 439–447.
16. Fernandez, D., Ghanta, A., Kauffman, G.W., Sanguinetti, M.C., Physicochemical features of the HERG channel drug binding site. J Biol Chem 279:11 (2004), 10120–10127.
17. Fischmeister, R., Castro, L., Abi-Gerges, A., Rochais, F., Vandecasteele, G., Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels. Comp Biochem Physiol A Mol Integr Physiol 142:2 (2005), 136–143.
18. Fish, J.M., Antzelevitch, C., Cellular and ionic basis for the sex-related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes. J Electrocardiol 36 (2003), 173–179 (Suppl).
19. Fulop, L., Banyasz, T., Szabo, G., Toth, I.B., Biro, T., Lorincz, I., et al. Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs. Acta Physiol (Oxf) 188:3–4 (2006), 163–171.
20. Furukawa, T., Kurokawa, J., Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias. Pharmacol Ther 115:1 (2007), 106–115.
21. Gaborit, N., Varro, A., Le Bouter, S., Szuts, V., Escande, D., Nattel, S., et al. Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts. J Mol Cell Cardiol 49:4 (2010), 639–646.
22. Golden, K.L., Marsh, J.D., Jiang, Y., Testosterone regulates mRNA levels of calcium regulatory proteins in cardiac myocytes. Horm Metab Res 36:4 (2004), 197–202.
23. Grace, A.A., Roden, D.M., Systems biology and cardiac arrhythmias. Lancet 380:9852 (2012), 1498–1508.
24. Hara, M., Danilo, P. Jr., Rosen, M.R., Effects of gonadal steroids on ventricular repolarization and on the response to E4031. J Pharmacol Exp Ther 285:3 (1998), 1068–1072.
25. Hashimoto, K., Arrhythmia models for drug research: classification of antiarrhythmic drugs. J Pharmacol Sci 103:4 (2007), 333–346.
26. Helguera, G., Olcese, R., Song, M., Toro, L., Stefani, E., Tissue-specific regulation of Ca(2 +) channel protein expression by sex hormones. Biochim Biophys Acta 1569:1–3 (2002), 59–66.
27. Honda, S., Harada, N., Ito, S., Takagi, Y., Maeda, S., Disruption of sexual behavior in male aromatase-deficient mice lacking exons 1 and 2 of the cyp19 gene. Biochem Biophys Res Commun 252:2 (1998), 445–449.
28. Hreiche, R., Morissette, P., Turgeon, J., Drug-induced long QT syndrome in women: review of current evidence and remaining gaps. Gend Med 5:2 (2008), 124–135.
29. Hulot, J.-S., Demolis, J.-L., Riviere, R., Strabach, S., Christin-Maitre, S., Funck-Brentano, C., Influence of endogenous oestrogens on QT interval duration. Eur Heart J 24:18 (2003), 1663–1667.
30. James, A.F., Choisy, S.C., Hancox, J.C., Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol 94:3 (2007), 265–319.
31. Janse de Jonge, X.A., Boot, C.R., Thom, J.M., Ruell, P.A., Thompson, M.W., The influence of menstrual cycle phase on skeletal muscle contractile characteristics in humans. J Physiol 530:Pt 1 (2001), 161–166.
32. Kadish, A.H., Greenland, P., Limacher, M.C., Frishman, W.H., Daugherty, S.A., Schwartz, J.B., Estrogen and progestin use and the QT interval in postmenopausal women. Ann Noninvasive Electrocardiol 9:4 (2004), 366–374.
33. Kakusaka, S., Asayama, M., Kaihara, A., Sasano, T., Suzuki, T., Kurokawa, J., et al. A receptor-independent effect of estrone sulfate on the HERG channel. J Pharmacol Sci 109:1 (2009), 152–156.
34. Kass, R.S., Kurokawa, J., Marx, S.O., Marks, A.R., Leucine/isoleucine zipper coordination of ion channel macromolecular signaling complexes in the heart. Roles in inherited arrhythmias. Trends Cardiovasc Med 13:2 (2003), 52–56.
35. Korte, T., Fuchs, M., Arkudas, A., Geertz, S., Meyer, R., Gardiwal, A., et al. Female mice lacking estrogen receptor beta display prolonged ventricular repolarization and reduced ventricular automaticity after myocardial infarction. Circulation 111:18 (2005), 2282–2290.
36. Kurokawa, J., Compartmentalized regulations of ion channels in the heart. Biol Pharm Bull 30:12 (2007), 2231–2237.
37. Kurokawa, J., Sasano, T., Kodama, M., Li, M., Ebana, Y., Harada, N., et al. Aromatase knockout mice reveal an impact of estrogen on drug-induced alternation of murine electrocardiography parameters. J Toxicol Sci 40:3 (2015), 339–348.
38. Kurokawa, J., Tamagawa, M., Harada, N., Honda, S., Bai, C.X., Nakaya, H., et al. Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization. J Physiol 586:Pt 12 (2008), 2961–2973.
39. Lehmann, M.H., Hardy, S., Archibald, D., Quart, B., MacNeil, D.J., Sex difference in risk of torsade de pointes with D,L-sotalol. Circulation 94:10 (1996), 2535–2541.
40. Liu, K., Ballew, C., Jacobs, D.R. Jr., Sidney, S., Savage, P.J., Dyer, A., et al. Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study. Hypertension 14:2 (1989), 218–226.
41. Locati, E.H., Zareba, W., Moss, A.J., Schwartz, P.J., Vincent, G.M., Lehmann, M.H., et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 97:22 (1998), 2237–2244.
42. Makkar, R.R., Fromm, B.S., Steinman, R.T., Meissner, M.D., Lehmann, M.H., Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 270:21 (1993), 2590–2597.
43. Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., et al. The nuclear receptor superfamily: the second decade. Cell 83:6 (1995), 835–839.
44. Marx, S.O., Kurokawa, J., Reiken, S., Motoike, H., D'Armiento, J., Marks, A.R., et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 295:5554 (2002), 496–499.
45. Merri, M., Benhorin, J., Alberti, M., Locati, E., Moss, A.J., Electrocardiographic quantitation of ventricular repolarization. Circulation 80:5 (1989), 1301–1308.
46. Murphy, E., Steenbergen, C., Mechanisms underlying acute protection from cardiac ischemia–reperfusion injury. Physiol Rev 88:2 (2008), 581–609.
47. Nakagawa, M., Ooie, T., Ou, B., Ichinose, M., Takahashi, N., Hara, M., et al. Gender differences in autonomic modulation of ventricular repolarization in humans. J Cardiovasc Electrophysiol 16:3 (2005), 278–284.
48. Nakagawa, M., Ooie, T., Takahashi, N., Taniguchi, Y., Anan, F., Yonemochi, H., et al. Influence of menstrual cycle on QT interval dynamics. Pacing Clin Electrophysiol 29:6 (2006), 607–613.
49. Nakamura, H., Kurokawa, J., Bai, C.X., Asada, K., Xu, J., Oren, R.V., et al. Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation 116:25 (2007), 2913–2922.
50. O'Hara, T., Virag, L., Varro, A., Rudy, Y., Simulation of the undiseased human cardiac ventricular action potential: model formulation and experimental validation. PLoS Comput Biol, 7(5), 2011, e1002061.
51. Pham, T.V., Robinson, R.B., Danilo, P. Jr., Rosen, M.R., Effects of gonadal steroids on gender-related differences in transmural dispersion of L-type calcium current. Cardiovasc Res 53:3 (2002), 752–762.
52. Rautaharju, P.M., Zhou, S.H., Wong, S., Calhoun, H.P., Berenson, G.S., Prineas, R., et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 8:7 (1992), 690–695.
53. Roberts, B.N., Yang, P.C., Behrens, S.B., Moreno, J.D., Clancy, C.E., Computational approaches to understand cardiac electrophysiology and arrhythmias. Am J Physiol Heart Circ Physiol 303:7 (2012), H766–H783.
54. Rodriguez, I., Kilborn, M.J., Liu, X.K., Pezzullo, J.C., Woosley, R.L., Drug-induced QT prolongation in women during the menstrual cycle. JAMA 285:10 (2001), 1322–1326.
55. Sanguinetti, M.C., Mitcheson, J.S., Predicting drug-hERG channel interactions that cause acquired long QT syndrome. Trends Pharmacol Sci 26:3 (2005), 119–124.
56. Satoh, Y., Sugiyama, A., Tamura, K., Hashimoto, K., Effects of mexiletine on the canine cardiovascular system complicating cisapride overdose: potential utility of mexiletine for the treatment of drug-induced long QT syndrome. Jpn J Pharmacol 83:4 (2000), 327–334.
57. Song, M., Helguera, G., Eghbali, M., Zhu, N., Zarei, M.M., Olcese, R., et al. Remodeling of Kv4.3 potassium channel gene expression under the control of sex hormones. J Biol Chem 276:34 (2001), 31883–31890.
58. Stramba-Badiale, M., Spagnolo, D., Bosi, G., Schwartz, P.J., Are gender differences in QTc present at birth? MISNES Investigators. Multicenter Italian Study on Neonatal Electrocardiography and Sudden Infant Death Syndrome. Am J Cardiol 75:17 (1995), 1277–1278.
59. Takahara, A., Nakamura, H., Nouchi, H., Tamura, T., Tanaka, T., Shimada, H., et al. Analysis of arrhythmogenic profile in a canine model of chronic atrioventricular block by comparing in vitro effects of the class III antiarrhythmic drug nifekalant on the ventricular action potential indices between normal heart and atrioventricular block heart. J Pharmacol Sci 103:2 (2007), 181–188.
60. Tamargo, J., Drug-induced torsade de pointes: from molecular biology to bedside. Jpn J Pharmacol 83:1 (2000), 1–19.
61. Verkerk, A.O., Wilders, R., Veldkamp, M.W., de Geringel, W., Kirkels, J.H., Tan, H.L., Gender disparities in cardiac cellular electrophysiology and arrhythmia susceptibility in human failing ventricular myocytes. Int Heart J 46:6 (2005), 1105–1118.
62. Vicente, J., Johannesen, L., Galeotti, L., Strauss, D.G., Mechanisms of sex and age differences in ventricular repolarization in humans. Am Heart J 168:5 (2014), 749–756.
63. Xiao, L., Zhang, L., Han, W., Wang, Z., Nattel, S., Sex-based transmural differences in cardiac repolarization and ionic-current properties in canine left ventricles. Am J Physiol Heart Circ Physiol 291:2 (2006), H570–H580.
64. Yang, P.C., Clancy, C.E., Effects of sex hormones on cardiac repolarization. J Cardiovasc Pharmacol 56:2 (2010), 123–129.
65. Yang, P.C., Clancy, C.E., Gender-based differences in cardiac diseases. J Biomed Res 25:2 (2011), 81–89.
66. Yang, P.C., Clancy, C.E., In silico prediction of sex-based differences in human susceptibility to cardiac ventricular tachyarrhythmias. Front Physiol, 3, 2012, 360.
67. Yang, P.C., Kurokawa, J., Furukawa, T., Clancy, C.E., Acute effects of sex steroid hormones on susceptibility to cardiac arrhythmias: a simulation study. PLoS Comput Biol, 6(1), 2010, e1000658.